| Financier | Commitments |
|---|---|
| IDA Credit | 50.00 |
KOSOVO EMERGENCY COVID-19 PROJECT
Abstract*
The project is in response to the request of the Government of Kosovo for support in preparing for and
responding to the COVID-19 pandemic and sustaining their efforts to prevent future outbreaks of emerging infectious
diseases. The project is prepared under the COVID-19 Strategic Preparedness and Response Program (SPRP) using the
Multiphase Programmatic Approach (MPA), approved by the World Bank’s Board of Executive Directors on April 2,
2020 (PCBASIC0219761)... Show More
Development Objective
The project development objective is to prevent, detect, and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Kosovo
Key Details
Project Details
P173819
Closed
Mrike Aliu , Ha Nguyen, Sarah Coll-Black
Republic of Kosovo
May 5, 2020
(as of board presentation)
May 20, 2020
September 3, 2020
US$ 50.00 million
Ministry of Finance, Labor and Transfers,Ministry of Health
2020
US$ 50.00 million
N/A
May 28, 2024
May 31, 2024
Yes
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 50.00 |
| IBRD + IDA Commitment | 50.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 50.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Feb 15, 2024 | IDA-66780 | Int Charges | 182,012.81 |
| Jun 28, 2024 | IDA-69630 | Loan Disb | 2,798,731.00 |
| Feb 28, 2024 | IDA-69630 | Loan Disb | 3,891,663.20 |
| May 20, 2020 | IDA-66780 | Loan Commitment | 50,000,000.00 |
| Jun 24, 2021 | IDA-69630 | Loan Commitment | 18,200,000.00 |
| Feb 15, 2021 | IDA-66780 | Int Charges | 60,043.12 |
| Feb 15, 2021 | IDA-66780 | Int Charges | 60,043.12 |
| Feb 15, 2021 | IDA-66780 | Int Charges | 20,874.22 |
| Dec 3, 2020 | IDA-66780 | Loan Disb | 276,990.60 |
| Dec 4, 2020 | IDA-66780 | Loan Disb | 11,618,140.00 |
| Dec 4, 2020 | IDA-66780 | Loan Disb | 22,389,120.00 |
| Dec 28, 2020 | IDA-66780 | Loan Disb | 9,720,289.00 |
| Aug 15, 2021 | IDA-66780 | Int Charges | 14,672.12 |
| Aug 15, 2021 | IDA-66780 | Int Charges | 159,261.45 |
| Aug 15, 2021 | IDA-66780 | Int Charges | 159,261.45 |
| Aug 15, 2021 | IDA-66780 | Int Charges | 95,556.87 |
| Dec 2, 2021 | IDA-66780 | Loan Disb | 1,564,213.10 |
| Oct 15, 2021 | IDA-66780 | Loan Disb | 840,114.70 |
| Dec 7, 2021 | IDA-69630 | Loan Disb | 6,117,031.50 |
| Feb 15, 2022 | IDA-66780 | Int Charges | 97,759.75 |
| Feb 15, 2022 | IDA-69630 | Int Charges | 8,733.54 |
| Feb 15, 2022 | IDA-69630 | Int Charges | 8,733.54 |
| Feb 15, 2022 | IDA-69630 | Int Charges | 1,746.71 |
| Feb 15, 2022 | IDA-66780 | Int Charges | 166,762.44 |
| Feb 15, 2022 | IDA-66780 | Int Charges | 166,762.44 |
| Dec 3, 2021 | IDA-66780 | Loan Disb | 4,714,532.50 |
| Aug 15, 2022 | IDA-69630 | Int Charges | 20,791.30 |
| Aug 15, 2022 | IDA-69630 | Int Charges | 20,791.30 |
| Aug 15, 2022 | IDA-66780 | Int Charges | 2,066.45 |
| Aug 15, 2022 | IDA-66780 | Int Charges | 167,161.23 |
| Aug 15, 2022 | IDA-66780 | Int Charges | 167,161.23 |
| Aug 15, 2022 | IDA-66780 | Int Charges | 100,296.73 |
| Dec 27, 2021 | IDA-66780 | Loan Disb | 1,432,151.10 |
| Aug 15, 2022 | IDA-69630 | Int Charges | 4,158.25 |
| Nov 30, 2022 | IDA-69630 | Loan Disb | 63,107.03 |
| Nov 21, 2022 | IDA-66780 | Loan Disb | 342,306.47 |
| Mar 10, 2023 | IDA-69630 | Loan Disb | 666,469.90 |
| Mar 1, 2023 | IDA-66780 | Loan Disb | 1,590,611.50 |
| Feb 15, 2023 | IDA-66780 | Int Charges | 176,093.78 |
| Feb 15, 2023 | IDA-66780 | Int Charges | 176,093.78 |
| Feb 15, 2023 | IDA-66780 | Int Charges | 105,656.26 |
| Feb 15, 2023 | IDA-69630 | Int Charges | 21,926.30 |
| Feb 15, 2023 | IDA-69630 | Int Charges | 21,926.30 |
| Feb 15, 2023 | IDA-69630 | Int Charges | 4,385.25 |
| Sep 4, 2023 | IDA-69630 | Loan Disb | -904,860.75 |
| Jul 11, 2023 | IDA-66780 | Loan Disb | -596,414.94 |
| Aug 15, 2023 | IDA-66780 | Int Charges | 185,640.72 |
| Aug 15, 2023 | IDA-66780 | Int Charges | 185,640.72 |
| Aug 15, 2023 | IDA-66780 | Int Charges | 111,384.45 |
| Aug 15, 2023 | IDA-69630 | Int Charges | 24,750.54 |
| Aug 15, 2023 | IDA-69630 | Int Charges | 24,750.54 |
| Aug 15, 2023 | IDA-69630 | Int Charges | 4,950.11 |
| Dec 1, 2023 | IDA-69630 | Loan Disb | 1,380,308.80 |
| Aug 15, 2024 | IDA-66780 | Int Charges | 189,929.60 |
| Aug 15, 2024 | IDA-66780 | Int Charges | 189,929.60 |
| Aug 15, 2024 | IDA-66780 | Int Charges | 113,957.75 |
| Dec 4, 2023 | IDA-66780 | Loan Disb | 1,115,168.00 |
| Aug 15, 2024 | IDA-69630 | Int Charges | 47,839.44 |
| Aug 15, 2024 | IDA-69630 | Int Charges | 47,839.44 |
| Aug 15, 2024 | IDA-69630 | Int Charges | 6,186.78 |
| Feb 27, 2024 | IDA-66780 | Loan Disb | 6,047.14 |
| May 21, 2024 | IDA-69630 | Loan Disb | 2,358,411.20 |
| Feb 15, 2024 | IDA-69630 | Int Charges | 23,735.08 |
| Feb 15, 2024 | IDA-69630 | Int Charges | 23,735.08 |
| Feb 15, 2024 | IDA-69630 | Int Charges | 4,747.03 |
| Feb 15, 2024 | IDA-66780 | Int Charges | 659.38 |
| Feb 15, 2024 | IDA-66780 | Int Charges | 659.38 |
| Feb 15, 2024 | IDA-66780 | Int Charges | 109,603.32 |
| Feb 15, 2024 | IDA-66780 | Int Charges | 182,012.81 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2025-02-10 |
| Financial Management | Satisfactory | 2025-02-10 |
| Monitoring and Evaluation | Satisfactory | 2025-02-10 |
| Overall Implementation Progress (IP) | Satisfactory | 2025-02-10 |
| Procurement | Satisfactory | 2025-02-10 |
| Project Management | Satisfactory | 2025-02-10 |
| Progress towards achievement of PDO | Satisfactory | 2025-02-10 |
| Financial Management | Satisfactory | 2025-02-10 |
| Monitoring and Evaluation | Satisfactory | 2025-02-10 |
| Overall Implementation Progress (IP) | Satisfactory | 2025-02-10 |
| Procurement | Satisfactory | 2025-02-10 |
| Project Management | Satisfactory | 2025-02-10 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of suspected cases of COVID19 reported and investigated per approved protocol Value 6351.00 1997612.00 356000.00 Date April 21, 2020 May 31, 2024 May 31, 2024 Comment Number of diagnosed cases treated per approved protocol Value 80.00 271309.00 14000.00 Date April 21, 2020 May 31, 2024 May 31, 2024 Comment Number of beneficiaries receiving financial support to enable social distancing Value 98096.00 310126.00 234192.00 Date April 21, 2020 December 11, 2023 June 30, 2023 Comment Percentage of population vaccinated, which is included in the priority population targets defined in the national plan (disaggregated by gender) Value 0.00 46.30 40.00 Date April 9, 2021 May 31, 2024 May 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of designated laboratories with COVID-19 diagnostic equipment, consumables, and reagents per MoH guidelines Value 0.00 6.00 6.00 Date April 21, 2020 December 11, 2023 May 31, 2024 Comment Beneficiaries reporting satisfaction with Government’s response to COVID-19 through its health system and SAS Value 0.00 52.00 70.00 Date April 22, 2020 May 31, 2024 May 31, 2024 Comment Number of medical staff in public health laboratories, trained to undertake contact tracing Value 0.00 28.00 28.00 Date April 21, 2020 December 11, 2023 May 31, 2024 Comment The number of communities engaged in participatory testing of the information products for COVID-19 vaccines Value 0.00 0.00 50.00 Date April 13, 2021 December 11, 2023 May 31, 2024 Comment Adoption of Government Decision to waive SAS exclusion criteria Value Not adopted Adopted SAS beneficiaries continue to be paid during publi Date April 16, 2020 December 11, 2023 June 30, 2023 Comment Number of healthcare workers trained on appropriate use of PPE, disease surveillance and prevention of the spread of respiratory infections within healthcare facilities Value 0.00 978.00 800.00 Date April 21, 2020 December 11, 2023 May 31, 2024 Comment Upgraded infrastructure in designated health facilities completed Value No Yes Yes Date April 21, 2020 December 11, 2023 May 31, 2024 Comment Number of ICU beds equipped and functional in the Infectious Disease Clinic Value 0.00 70.00 60.00 Date April 21, 2020 December 11, 2023 May 31, 2024 Comment Number of volunteer healthcare staff covered with salaries for at least 3 months Value 0.00 338.00 400.00 Date April 21, 2020 December 11, 2023 May 31, 2024 Comment Number of Primary Healthcare Centers (PHCs) equipped with essential drugs Value 0.00 31.00 28.00 Date April 9, 2021 December 11, 2023 May 31, 2024 Comment Percentage of trained PHC healthcare workers with the knowledge to recognize and refer GBV victims during the pandemic Value 0.00 26.90 20.00 Date April 14, 2021 December 11, 2023 May 31, 2024 Comment Number of Primary Healthcare Centers (PHCs) receiving vehicles for outreach Value 0.00 23.00 15.00 Date August 8, 2022 May 31, 2024 May 31, 2024 Comment